MASH-hepatic disorders therapy(Pramana Pharmaceuticals Inc)

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameMASH-hepatic disorders therapy(Pramana Pharmaceuticals Inc)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesPramana Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPramana Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A